Open AccessManaging advanced EGFR-positive NSCLC - a short review
Author(s) -
Alexandru Grigorescu
Publication year - 2017
Publication title -
oncolog-hematolog ro
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2066-8716
pISSN - 2066-8260
DOI - 10.26416/onhe.39.2.2017.727
Subject(s) - afatinib , erlotinib , gefitinib , medicine , oncology , osimertinib , lung cancer , acquired resistance , disease , chemotherapy , intensive care medicine , cancer , epidermal growth factor receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom